dc.contributor.author | Altalhe, Heba Abdalnasser Azouz | |
dc.date.accessioned | 2019-06-25T09:09:41Z | |
dc.date.available | 2019-06-25T09:09:41Z | |
dc.date.issued | 2019-04-09 | |
dc.identifier.uri | http://repository.limu.edu.ly/handle/123456789/991 | |
dc.description | Angiotensin converting enzyme inhibitors (ACE inhibitors) are
medications that inhibit the activity of the enzyme ACE, which
decreases the production of angiotensin II. As a result, blood vessels
dilate, and blood pressure is reduced ,the are effective drugs used in
the treatment of hypertension[1]. Although these drugs have been
shown to be relatively safe in the short term, concerns have been
raised that their long term use may be associated with an increased
risk of cancer. [2],The Some biological evidence exists for a possible
association between ACEIs and risk of lung cancer. | en_US |
dc.language.iso | en | en_US |
dc.publisher | faculty of Basic Medical Science - Libyan International Medical University | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.title | Angiotensin-converting enzyme inhibitors can be a risk factor for lung cancer!! | en_US |
dc.type | Other | en_US |